EUVIMEDEUVIMED entdecken
Fallbericht

Off-Label Teplizumab Treatment for Adult-Onset Autoimmune Type 1 Diabetes Initially Misdiagnosed As Type 2 Diabetes: A Case Report

Lilian A Maturell Rojas, Lisset Urquiza Portilla, Yoniel Suarez-Guerrero, Annabell Castro, Andy M Vinent Rodriguez, Kwame Ntim

Cureus · 17.11.2026

DOI: 10.7759/cureus.119823 ↗

Kurz gefasst

Fallbericht in der Zeitschrift Cureus, erschienen am 17.11.2026. Verfasst von Lilian A Maturell Rojas und 5 weiteren Autor:innen. Die Arbeit nennt 12 Literaturangaben.

AbstractBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Kein Abstract verfügbar.

Zitieren

APA

Rojas, L. A. M., Portilla, L. U., Suarez-Guerrero, Y., Castro, A., Rodriguez, A. M. V., & Ntim, K. (2026). Off-Label Teplizumab Treatment for Adult-Onset Autoimmune Type 1 Diabetes Initially Misdiagnosed As Type 2 Diabetes: A Case Report. Cureus. https://doi.org/10.7759/cureus.119823

Vancouver

Rojas LAM, Portilla LU, Suarez-Guerrero Y, Castro A, Rodriguez AMV, Ntim K. Off-Label Teplizumab Treatment for Adult-Onset Autoimmune Type 1 Diabetes Initially Misdiagnosed As Type 2 Diabetes: A Case Report. Cureus. 2026. doi:10.7759/cureus.119823

BibTeX
@article{Rojas2026,
  author = {Rojas, Lilian A Maturell and Portilla, Lisset Urquiza and Suarez-Guerrero, Yoniel and Castro, Annabell and Rodriguez, Andy M Vinent and Ntim, Kwame},
  title = {Off-Label Teplizumab Treatment for Adult-Onset Autoimmune Type 1 Diabetes Initially Misdiagnosed As Type 2 Diabetes: A Case Report},
  journal = {Cureus},
  year = {2026},
  doi = {10.7759/cureus.119823}
}
Kostenlos starten →